echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Production Process of ETHYL 3-BROMOIMIDAZO[1,2-A]PYRIMIDINE-2-CARBOXYLATE

    The Production Process of ETHYL 3-BROMOIMIDAZO[1,2-A]PYRIMIDINE-2-CARBOXYLATE

    • Last Update: 2023-05-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate is a chemical compound that is widely used in the pharmaceutical industry as an intermediate for the synthesis of certain drugs.
    The production process of this compound involves several steps, which are carried out in a chemical plant equipped with the necessary equipment and machinery.


    Step 1: Production of 3-bromoimidazo[1,2-a]pyrimidine
    The first step in the production of ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate is the production of 3-bromoimidazo[1,2-a]pyrimidine.
    This is done by reacting 3-bromopyridine with a nucleophile, such as hydroxylamine or ammonia, in the presence of a solvent, such as dichloromethane or chloroform.
    The reaction is catalyzed by a strong acid, such as sulfuric acid or phosphoric acid.


    Step 2: Production of 2-chloro-4-[[[(4S)-4-(dibromoethyl)-2,6-dimethyl-1,4-oxazepin-3-yl]acetyl]amino]benzoic acid
    The next step is the production of 2-chloro-4-[[[(4S)-4-(dibromoethyl)-2,6-dimethyl-1,4-oxazepin-3-yl]acetyl]amino]benzoic acid, which is the intermediate compound for ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate.
    This is done by reacting 2,6-dimethyl-1,4-oxazepin-3-one with 2,4-dibromo-acetoacetic acid in the presence of an acid catalyst, such as sulfuric acid or phosphoric acid.
    The reaction is carried out in a suitable solvent, such as chloroform or dichloromethane.


    Step 3: Production of Ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate
    The final step in the production process of ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate is the esterification of 2-chloro-4-[[[(4S)-4-(dibromoethyl)-2,6-dimethyl-1,4-oxazepin-3-yl]acetyl]amino]benzoic acid with ethanol in the presence of an acid catalyst, such as sulfuric acid or phosphoric acid.
    The reaction is carried out in a suitable solvent, such as water or ethanol.


    Quality Control:


    The production process of ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate is a complex process that involves several steps.
    To ensure the quality of the final product, it is important to conduct regular quality control tests at each stage of the process.
    These tests may include chemical analysis, microbiological testing, and physical testing, such as melting point and solubility tests.


    Safety Precautions:


    The production process of ethyl 3-bromoimidazo[1,2-a]pyrimidine-2-carboxylate involves the use of various chemicals and reagents.
    It is important to follow safety precautions to prevent accidents and ensure the health and safety of workers in the chemical plant.
    Safety measures may include the provision of protective equipment, such as


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.